tiprankstipranks
Avolta (DUFRY)
OTHER OTC:DUFRY
Want to see DUFRY full AI Analyst Report?

Avolta (DUFRY) AI Stock Analysis

72 Followers

Top Page

DUFRY

Avolta

(OTC:DUFRY)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - Gpt-5.6Sol)
Rating:60Neutral
Price Target:
$5.50
▼(-6.30% Downside)
Action:Reiterated
Date:07/31/26
The score is driven mainly by improving fundamentals and strong cash generation, supported by a generally positive earnings-call outlook with reiterated guidance and ongoing buybacks/dividend increases. Offsetting these positives are balance-sheet risk from high leverage and a relatively expensive valuation (high P/E), while technicals indicate near-term weakness versus key short- and medium-term moving averages.
Positive Factors
Strong cash generation
Consistently positive and rising cash generation indicates that reported earnings are supported by cash rather than accruals. This gives Avolta capacity to fund concessions, reduce debt, maintain dividends, and pursue growth while preserving financial flexibility.
Negative Factors
Very high balance-sheet leverage
A large debt burden relative to the equity base reduces financial flexibility and leaves less capacity to absorb weaker travel conditions or unexpected operating pressure. Although leverage has improved, elevated debt still increases refinancing and cash-allocation risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Consistently positive and rising cash generation indicates that reported earnings are supported by cash rather than accruals. This gives Avolta capacity to fund concessions, reduce debt, maintain dividends, and pursue growth while preserving financial flexibility.
Read all positive factors

Avolta (DUFRY) vs. SPDR S&P 500 ETF (SPY)

Avolta Business Overview & Revenue Model

Company Description
Avolta AG, a company established in 1865 and based in Basel, Switzerland, functions as a leading global entity in the travel retail sector. Renamed in November 2023 from its former identity as Dufry AG, Avolta manages an extensive portfolio of ret...
How the Company Makes Money
Avolta makes money primarily by operating retail and food & beverage concessions in travel environments (most notably airports) under multi-year contracts with airport authorities and other venue operators. Retail revenue is generated from the sal...

Avolta Earnings Call Summary

Earnings Call Date:Jul 30, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:Mar 09, 2027
Earnings Call Sentiment Positive
The call presents a cautiously optimistic, overall positive picture: the company delivered resilient H1 sales (3.7% organic) and core EBITDA (CHF 583m) while generating record Q2 cash flow and continuing deleveraging and shareholder returns. Management also highlighted strategic commercial wins (JFK, Pudong), accretive M&A (Okinawa), and meaningful progress on digital and loyalty initiatives (Club Avolta 20m members). However, material near-term headwinds remain — chiefly the Middle East crisis, large ramp-up costs at Pudong and JFK, and FX-related translation losses — which together depressed margins by roughly ~40 basis points and produced regional volatility. On balance, the positive operational momentum, strong cash generation in Q2, active capital allocation and sustained strategic wins moderately outweigh the temporary headwinds, supporting a cautiously Positive outlook.
Positive Updates
Solid H1 Sales and Organic Growth
Turnover of CHF 6.437 billion in H1 2026 with reported organic growth of 3.7% (would have been 5.2% net of Middle East impact). Growth at constant exchange was 3.1% for the half year.
Negative Updates
Middle East Crisis Headwind
Ongoing Middle East volatility materially impacted results (EMEA only +1.9% organic growth, which would be +4.6% net of the Middle East). Management attributes a meaningful portion of the EBITDA drag to the crisis; Middle East effects are volatile and uncertain.
Read all updates
Q2-2026 Updates
Negative
Solid H1 Sales and Organic Growth
Turnover of CHF 6.437 billion in H1 2026 with reported organic growth of 3.7% (would have been 5.2% net of Middle East impact). Growth at constant exchange was 3.1% for the half year.
Read all positive updates
Company Guidance
Management reiterated mid‑term guidance of 5–7% organic growth, an EBITDA margin expansion of 20–40 basis points per year and year‑on‑year increases in equity free cash flow, while confirming a disciplined capital allocation: dividend = one‑third of cash flow (third consecutive increase), net debt/EBITDA target 1.5–2.0x (temporarily up to 2.5x for M&A), and a EUR 225m share buyback (≈EUR 106m executed by June 30; ~half completed; treasury purchases ≈EUR 160m H1); leverage has improved to ~2.07x (down ~0.1x YoY). H1 figures supporting the outlook included turnover CHF 6.437bn, organic growth 3.7% (5.2% ex‑Middle East), core EBITDA CHF 583m (9.1% margin; 9.5% margin ex‑Middle East and ramp‑up effects), equity free cash flow ~207m, CapEx ~3% of sales in H1, and an expected full‑year FX headwind of ~‑3.5%; management expects ramp‑up headwinds (Pudong/JFK) to fade through 2026 and normalize by 2027.

Avolta Financial Statement Overview

Summary
Operating recovery and profitability improvement since 2022 plus strong, rising free cash flow are key positives. However, the balance sheet is a major constraint: very high leverage (debt ~11.46B vs equity ~1.91B; ~6.0x debt-to-equity) and limited equity cushion raise financial risk despite improving returns.
Income Statement
68
Positive
Balance Sheet
38
Negative
Cash Flow
75
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue13.90B13.98B13.72B12.79B6.88B3.92B
Gross Profit4.19B8.95B8.80B3.92B4.19B2.21B
EBITDA2.93B2.78B2.84B2.47B1.62B-258.90M
Net Income206.33M190.05M103.00M87.30M58.20M-385.40M
Balance Sheet
Total Assets17.28B16.31B17.40B16.51B9.31B9.99B
Cash, Cash Equivalents and Short-Term Investments989.49M727.83M756.00M769.50M854.70M793.50M
Total Debt12.42B11.46B11.91B11.19B6.58B7.45B
Total Liabilities15.51B14.26B14.88B14.02B8.34B8.96B
Stockholders Equity1.60B1.91B2.35B2.36B893.00M956.60M
Cash Flow
Free Cash Flow2.51B2.30B2.12B1.92B1.40B587.00M
Operating Cash Flow2.94B2.73B2.60B2.36B1.51B678.20M
Investing Cash Flow-525.39M-453.65M-312.00M-1.00M-67.40M-72.80M
Financing Cash Flow-2.37B-2.21B-2.18B-2.40B-1.34B-136.20M

Avolta Technical Analysis

Technical Analysis Sentiment
Negative
Last Price5.87
Price Trends
50DMA
5.93
Negative
100DMA
5.97
Negative
200DMA
5.97
Negative
Market Momentum
MACD
-0.20
Positive
RSI
27.30
Positive
STOCH
8.11
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DUFRY, the sentiment is Negative. The current price of 5.87 is above the 20-day moving average (MA) of 5.65, below the 50-day MA of 5.93, and below the 200-day MA of 5.97, indicating a bearish trend. The MACD of -0.20 indicates Positive momentum. The RSI at 27.30 is Positive, neither overbought nor oversold. The STOCH value of 8.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DUFRY.

Avolta Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$23.38B19.9145.40%1.13%11.16%5.20%
73
Outperform
$2.77T20.1230.50%15.77%88.63%
72
Outperform
$47.95B22.0648.28%1.12%15.18%7.28%
70
Outperform
$1.49B8.0523.11%1.08%3.88%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
60
Neutral
$7.41B29.1811.78%2.29%7.88%96.56%
60
Neutral
$2.76B15.0411.79%7.34%30.43%-44.33%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DUFRY
Avolta
5.21
-0.46
-8.20%
AMZN
Amazon
253.54
19.49
8.33%
EBAY
eBay
108.99
21.26
24.23%
SBH
Sally Beauty
16.01
0.95
6.31%
ULTA
Ulta Beauty
548.65
23.44
4.46%
MNSO
MINISO Group Holding
9.07
-15.17
-62.59%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 31, 2026